Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 8:02 pm Purchase | 2025-04-22 | 13D | Panbela Therapeutics, Inc. PBLA | Nant Capital, LLC | 32,432,432 86.980% | 30,005,366 (+1236.28%) | Filing History |
| 2024-10-29 7:40 pm Purchase | 2024-10-22 | 13D | Panbela Therapeutics, Inc. PBLA | Nant Capital, LLC | 2,427,066 33.330% | 2,427,066 (New Position) | Filing History |
| 2024-02-13 8:10 pm Unchanged | 2023-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:45 pm Purchase | 2022-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 58 3.300% | 22 (+60.55%) | Filing History |
| 2023-01-30 4:38 pm Purchase | 2023-01-30 | 13G | Panbela Therapeutics, Inc. PBLA | Lind Global Fund II LP | 983 9.900% | 983 (New Position) | Filing History |
| 2022-02-14 5:20 pm Purchase | 2021-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 36 6.300% | 2 (+5.57%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Cullen Michael T. | 34 8.200% | 34 (New Position) | Filing History |
| 2021-02-16 4:01 pm Purchase | 2020-12-31 | 13G | Panbela Therapeutics, Inc. PBLA | Schemel Donald Robert | 19 4.600% | 19 (New Position) | Filing History |
| 2020-09-08 5:15 pm Purchase | 2020-08-28 | 13G | SUN BIOPHARMA INC SNBP | Armistice Capital, LLC | 497,029 4.990% | 497,029 (New Position) | Filing History |